Characterization of Patients With Severe Asthma Who Initiated Biologic Treatment Within ≤90 and >90 Days After Biologic EligibilityNatalia Petruski‐Ivleva, Nella Bieszk, Richard H. Stanford et al.|Unknown|2024Cited by 0
EE225 Burden of Chronic Obstructive Pulmonary Disease (COPD) Healthcare Costs in Patients with Moderate-to-Severe DiseaseRobert Lubwama, WH Cheng, Duane Madziva et al.|Value in Health|2024Cited by 0
EE730 Health Care Resource Utilization (HCRU) in Chronic Obstructive Pulmonary Disease (COPD), and Asthma Patients With Moderate-to-Severe DiseaseE. Mayen Herrera, WH Cheng, Robert Lubwama et al.|Value in Health|2024Cited by 0
Impact Of Race on Baseline Asthma Severity and Response to Biologic Therapy in the First 12 Months Post Biologic InitiationMonica Littlejohn, Natalia Petruski‐Ivleva, Caresse Campbell et al.|Journal of Allergy and Clinical Immunology|2025Cited by 0